GT
ETNB

Glenmede Trust’s 89bio ETNB Stock Holding History

Glenmede Trust’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,338
Closed -$187K – 1300
2022
Q3 		$187K Hold
32,338
– – ﹤0.01% 1096
2022
Q2 		$104K Hold
32,338
– – ﹤0.01% 1153
2022
Q1 		$121K Buy
32,338
+14,409
+80% +$92.8K ﹤0.01% 1181
2021
Q4 		$234K Hold
17,929
– – ﹤0.01% 1108
2021
Q3 		$351K Hold
17,929
– – ﹤0.01% 988
2021
Q2 		$335K Sell
17,929
-4,738
-21% -$106K ﹤0.01% 1002
2021
Q1 		$536K Hold
22,667
– – ﹤0.01% 827
2020
Q4 		$552K Buy
+22,667
New +$580K ﹤0.01% 821

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Glenmede Trust's ETNB Position: Q4 2022 in Review

Glenmede Trust sold out of 89bio (ETNB) in Q4 2022, closing a stake of 32,338 shares — an estimated $187K sold.

Glenmede Trust first reported a position in ETNB in Q4 2020 and held it in 8 quarters. The position peaked at $552K in Q4 2020. 106 funds tracked by Wall St. Rank hold ETNB as of Q4 2022.

  • Glenmede Trust reported no remaining 89bio position as of Q4 2022 after selling out during the quarter.
  • Glenmede Trust sold 32,338 89bio shares in Q4 2022, an estimated $187K.
  • Glenmede Trust first reported a position in 89bio in Q4 2020 and held it in 8 quarters.
  • Glenmede Trust's 89bio position peaked at $552K in Q4 2020.
  • 106 funds tracked by Wall St. Rank held 89bio as of Q4 2022.

Based on Glenmede Trust's 13F filing for Q4 2022, filed 14 Feb 2023.